Which statement reflects the USPSTF position on prescribing a statin for cardiovascular disease prevention?

Which statement reflects the USPSTF position on prescribing a statin for cardiovascular disease prevention?

• A. Adults aged 40-75 with 1+ risk factors and an estimated 10-year risk of 10% or greater.
• B. Adults over 75 only.
• C. All adults regardless of risk.
• D. Adults aged 20-39 with no risk factors.

Answer: (D)

The main concept here is that USPSTF guidance on statins for primary prevention is risk-based and targeted to a specific adult age range. The USPSTF recommends starting statin therapy for primary prevention in adults aged 40–75 who have a 10-year ASCVD risk of 10% or greater, after shared decision-making that weighs the benefits and possible harms. This reflects that the greatest net benefit occurs in people with meaningful calculated risk, not in all adults or in very young people. So the statement that best reflects USPSTF position is that statins are recommended for adults 40–75 with a 10-year ASCVD risk of 10% or higher. This is not a blanket recommendation for all adults, nor is it appropriate to routinely prescribe statins to adults over 75 without individualized consideration, and it’s not advised for adults aged 20–39 with no risk factors because the evidence for benefit in that group is lacking.

The main concept here is that USPSTF guidance on statins for primary prevention is risk-based and targeted to a specific adult age range. The USPSTF recommends starting statin therapy for primary prevention in adults aged 40–75 who have a 10-year ASCVD risk of 10% or greater, after shared decision-making that weighs the benefits and possible harms. This reflects that the greatest net benefit occurs in people with meaningful calculated risk, not in all adults or in very young people.

So the statement that best reflects USPSTF position is that statins are recommended for adults 40–75 with a 10-year ASCVD risk of 10% or higher. This is not a blanket recommendation for all adults, nor is it appropriate to routinely prescribe statins to adults over 75 without individualized consideration, and it’s not advised for adults aged 20–39 with no risk factors because the evidence for benefit in that group is lacking.